FASEB J. Avanti Polar Lipids
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.08-119420.
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Supplemental Data
Right arrow All Versions of this Article:
fj.08-119420v1
23/2/586    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Makowski, L.
Right arrow Articles by Muoio, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Makowski, L.
Right arrow Articles by Muoio, D. M.
(The FASEB Journal. 2009;23:586-604.)
© 2009 FASEB

Metabolic profiling of PPAR{alpha}–/– mice reveals defects in carnitine and amino acid homeostasis that are partially reversed by oral carnitine supplementation

Liza Makowski*,§, Robert C. Noland*,§, Timothy R. Koves*,{dagger},§, Weibing Xing*,§, Olga R. Ilkayeva*,§, Michael J. Muehlbauer*,§, Robert D. Stevens*,§ and Deborah M. Muoio*,{ddagger},§,1

* Division of Endocrinology, Metabolism, and Nutrition, and

{dagger} Division of Geriatrics, Department of Medicine,

{ddagger} Department of Pharmacology and Cancer Biology, and

§ Sarah W. Stedman Nutrition and Metabolism Center, Duke University School of Medicine, Durham, North Carolina, USA

1Correspondence: 4321 Medical Park Dr., Ste. 200, Durham, NC 27704, USA. E-mail: muoio{at}duke.edu

Peroxisome proliferator-activated receptor-{alpha} (PPAR{alpha}) is a master transcriptional regulator of β-oxidation and a prominent target of hypolipidemic drugs. To gain deeper insights into the systemic consequences of impaired fat catabolism, we used quantitative, mass spectrometry-based metabolic profiling to investigate the fed-to-fasted transition in PPAR{alpha}+/+ and PPAR{alpha}–/– mice. Compared to PPAR{alpha}+/+ animals, acylcarnitine profiles of PPAR{alpha}–/– mice revealed 2- to 4-fold accumulation of long-chain species in the plasma, whereas short-chain species were reduced by as much as 69% in plasma, liver, and skeletal muscle. These results reflect a metabolic bottleneck downstream of carnitine palmitoyltransferase-1, a mitochondrial enzyme that catalyzes the first step in β-oxidation. Organic and amino acid profiles of starved PPAR{alpha}–/– mice suggested compromised citric acid cycle flux, enhanced urea cycle activity, and increased amino acid catabolism. PPAR{alpha}–/– mice had 40–50% lower plasma and tissue levels of free carnitine, corresponding with diminished hepatic expression of genes involved in carnitine biosynthesis and transport. One week of oral carnitine supplementation conferred partial metabolic recovery in the PPAR{alpha}–/– mice. In summary, comprehensive metabolic profiling revealed novel biomarkers of defective fat oxidation, while also highlighting the potential value of supplemental carnitine as a therapy and diagnostic tool for metabolic disorders.—Makowski, L., Noland, R. C., Koves, T. R., Xing, W., Ilkayeva, O. R., Muehlbauer, M. J., Stevens, R. D., Muoio, D. M. Metabolic profiling of PPAR{alpha}–/– mice reveals defects in carnitine and amino acid homeostasis that are partially reversed by oral carnitine supplementation.


Key Words: β-oxidation • metabolomics • liver • skeletal muscle • acylcarnitine • organic acid • starvation




This article has been cited by other articles:


Home page
DiabetesHome page
J. R. Bain, R. D. Stevens, B. R. Wenner, O. Ilkayeva, D. M. Muoio, and C. B. Newgard
Metabolomics Applied to Diabetes Research: Moving From Information to Knowledge
Diabetes, November 1, 2009; 58(11): 2429 - 2443.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. C. Noland, T. R. Koves, S. E. Seiler, H. Lum, R. M. Lust, O. Ilkayeva, R. D. Stevens, F. G. Hegardt, and D. M. Muoio
Carnitine Insufficiency Caused by Aging and Overnutrition Compromises Mitochondrial Performance and Metabolic Control
J. Biol. Chem., August 21, 2009; 284(34): 22840 - 22852.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by The Federation of American Societies for Experimental Biology.